Table 2 Baseline clinical characteristics
Baseline clinic characteristics | N = 33 n (%) |
|---|---|
Disease diagnosis time in yearsa | 2 (1–5,5) |
SLE manifestation | |
• Renal | 27 (81,8) |
• Articular | 19 (57,6) |
• Hematological | 19 (57,6) |
• Mucocutaneous | 18 (54,5) |
• Serositis | 8 (24,2) |
• Central Nervous System | 8 (24,2) |
• Pulmonary | 4 (12,1) |
Previous hospitalization | 28 (84,8) |
Previous hospitalization daysa | 5 (1–15) |
Previous ICU admission | 4 (12,1) |
Outpatient treatment | |
• Steroids | 28 (84,8) |
• Chloroquine | 22 (66,6) |
• Rituximab | 4 (12,1) |
• Azathioprine | 4 (12,1) |
• Mycophenolate | 4 (12,1) |
• Cyclophosphamide | 2 (6,0) |
• Methotrexate | 1 (3,0) |
• Leflunomide | 1 (3,0) |
• Calcineurin inhibitors | 1 (3,0) |